CO
$54.82
-1.61
(-2.85%)
As of Oct 7, 2026, 3:19 PM EDT
Price history
Cooper Companies (The) (COO) is trading down at $54.82 (-2.85%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Cooper Companies (The) revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Oct 2016 | FY2017Oct 2017 | FY2018Oct 2018 | FY2019Oct 2019 | FY2020Oct 2020 | FY2021Oct 2021 | FY2022Oct 2022 | FY2023Oct 2023 | FY2024Oct 2024 | FY2025Oct 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.97B | $2.14B | $2.53B | $2.65B | $2.43B | $2.92B | $3.31B | $3.59B | $3.90B | $4.09B |
| Growth (year over year) | +9.4% | +8.8% | +18.4% | +4.8% | −8.4% | +20.2% | +13.2% | +8.6% | +8.4% | +5.1% |
| Gross profit | $1.17B | $1.37B | $1.63B | $1.76B | $1.53B | $1.96B | $2.14B | $2.36B | $2.60B | $2.68B |
| Gross margin | 59.6% | 63.9% | 64.4% | 66.2% | 63.1% | 66.9% | 64.7% | 65.6% | 66.6% | 65.5% |
| Operating income | $324.1M | $429.1M | $403.1M | $546.7M | $311.8M | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M |
| Operating margin | 16.5% | 20.1% | 15.9% | 20.6% | 12.8% | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| Net income | $273.9M | $372.9M | $139.9M | $466.7M | $238.4M | $2.94B | $385.8M | $294.2M | $392.3M | $374.9M |
| Net margin | 13.9% | 17.4% | 5.5% | 17.6% | 9.8% | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
| EPS (diluted) | $1.40 | $1.88 | $0.70 | $2.33 | $1.20 | $14.79 | $1.94 | $1.48 | $1.96 | $1.87 |
| Balance sheet | ||||||||||
| Cash and equivalents | $100.8M | $88.8M | $77.7M | $89.0M | $115.9M | $95.9M | $138.2M | $120.8M | $107.6M | $110.6M |
| Total assets | $4.48B | $4.86B | $6.11B | $6.27B | $6.74B | $9.61B | $11.5B | $11.7B | $12.3B | $12.4B |
| Total liabilities | $1.78B | $1.68B | $2.81B | $2.65B | $2.91B | $2.66B | $4.32B | $4.11B | $4.23B | $4.16B |
| Long-term debt | $1.11B | $1.15B | $1.99B | $1.26B | $1.38B | $1.40B | $2.35B | $2.52B | $2.55B | $2.46B |
| Shareholders' equity | $2.70B | $3.18B | $3.31B | $3.63B | $3.82B | $6.94B | $7.17B | $7.55B | $8.08B | $8.24B |
| Cash flow | ||||||||||
| Operating cash flow | $509.6M | $593.6M | $668.9M | $713.2M | $486.6M | $738.6M | $692.4M | $607.5M | $709.3M | $796.1M |
| Capital expenditure | $152.6M | $127.2M | $193.6M | $292.1M | $310.4M | $214.4M | $242.0M | $392.5M | $421.2M | $362.4M |
| Free cash flow | $357.0M | $466.4M | $475.3M | $421.1M | $176.2M | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| Dividends paid | $2.90M | $2.90M | $2.90M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $0 | $0 |
| Share buybacks | $0 | $55.0M | $0 | $156.1M | $47.8M | $24.8M | $78.5M | $0 | $0 | $290.1M |
RevenueNet income
| Q4 FY24†Oct 2024 | Q1 FY25Jan 2025 | Q2 FY25Apr 2025 | Q3 FY25Jul 2025 | Q4 FY25†Oct 2025 | Q1 FY26Jan 2026 | Q2 FY26Apr 2026 | Q3 FY26Jul 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.02B | $964.7M | $1.00B | $1.06B | $1.07B | $1.02B | $1.08B | $1.07B |
| Growth (year over year) | +9.8% | +3.6% | +6.3% | +5.7% | +4.6% | +6.2% | +7.9% | +0.6% |
| Gross profit | $677.7M | $660.2M | $679.1M | $692.0M | $650.8M | $695.2M | $735.4M | $711.9M |
| Gross margin | 66.5% | 68.4% | 67.8% | 65.3% | 61.1% | 67.9% | 68.0% | 66.8% |
| Operating income | $198.4M | $182.0M | $184.8M | $175.7M | $140.4M | $212.8M | −$31.0M | $222.0M |
| Operating margin | 19.5% | 18.9% | 18.4% | 16.6% | 13.2% | 20.8% | −2.9% | 20.8% |
| Net income | $117.5M | $104.3M | $87.7M | $98.3M | $84.6M | $130.8M | −$77.9M | $432.8M |
| Net margin | 11.5% | 10.8% | 8.7% | 9.3% | 7.9% | 12.8% | −7.2% | 40.6% |
| EPS (diluted) | $0.59 | $0.52 | $0.44 | $0.49 | $0.42 | $0.66 | −$0.40 | $2.24 |
| Balance sheet | ||||||||
| Cash and equivalents | $107.6M | $100.9M | $116.2M | $124.9M | $110.6M | $124.9M | $138.8M | $154.7M |
| Total assets | $12.3B | $12.2B | $12.4B | $12.4B | $12.4B | $12.4B | $12.5B | $12.7B |
| Total liabilities | $4.23B | $4.09B | $4.13B | $4.02B | $4.16B | $4.06B | $4.24B | $4.34B |
| Long-term debt | $2.55B | $2.49B | $2.52B | $2.43B | $2.46B | $1.88B | $1.86B | $1.91B |
| Shareholders' equity | $8.08B | $8.13B | $8.29B | $8.35B | $8.24B | $8.36B | $8.24B | $8.33B |
| Cash flow | ||||||||
| Operating cash flow | $268.1M | $190.6M | $96.2M | $261.4M | $247.9M | $260.9M | $182.8M | $341.7M |
| Capital expenditure | $140.0M | $89.4M | $78.1M | $96.9M | $98.0M | $102.2M | $86.4M | $68.7M |
| Free cash flow | $128.1M | $101.2M | $18.1M | $164.5M | $149.9M | $158.7M | $96.4M | $273.0M |
| Dividends paid | $0 | — | — | — | — | — | — | — |
| Share buybacks | $0 | $0 | $40.6M | $52.7M | $196.8M | $92.5M | $15.5M | $339.2M |
From Cooper Companies (The)'s 10-K and 10-Q filings with the SEC; its fiscal year ends in October. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Cooper Companies (The)
- Headquarters
- San Ramon, California From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- BSX Boston Scientific
- CAH Cardinal Health
- CI Cigna
- CNC Centene Corporation
- COR Cencora
- CRL Charles River Laboratories
- CVS CVS Health
- DGX Quest Diagnostics